3 September 2019
At the meeting of 7 August 2019 the RMA:
Determined Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
Morton metatarsalgia | 77/2019 | 78/2019 |
varicocoele | 79/2019 | 80/2019 |
conductive hearing loss | 81/2019 | 82/2019 |
malignant neoplasm of the bladder | 83/2019 | 84/2019 |
obstructive and reflux nephropathy | 85/2019 | 86/2019 |
anal fissure | 87/2019 | 88/2019 |
The investigation concerning 'varicocele' has resulted in the determination of Statements of Principles concerning varicocoele.
The investigation concerning 'Morton's metatarsalgia' has resulted in the determination of Statements of Principles concerning Morton metatarsalgia.
Determined Amendment Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
hypertension | 89/2019 |
The above SOPs take effect from 23 September 2019.
Summary of Changes
Finalised Declaration for:
Condition | Declaration | Reasons for Decision |
---|---|---|
hypertension |
Completed Investigations
The above determinations and declarations conclude the previously advertised investigations into:
- Morton metatarsalgia
- varicocoele
- conductive hearing loss
- malignant neoplasm of the bladder
- obstructive and reflux nephropathy
- anal fissure
- hypertension (focussed - exposure to phenoxyherbicides/dioxin (Agent Orange))
New Investigation
Decided to advertise the following investigation:
- migraine (focussed review - definition of migraine)
The above declaration and investigation notice appear in the Government Notices Gazette of 3 September 2019.